Serum S-100 protein, relationship to clinical outcome in acute stroke

Annals of Clinical Biochemistry

Volumn 34, Issue 4, 1997, Pages 366-370

  Abraha, Hagosa D ^a   Butterworth, Richard J ^a   Bath, Philip M W ^a   Wassif, Wassif S ^a   Garthwaite, John ^b   Sherwood, Roy A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b WELLCOME RESEARCH LABORATORIES   (United Kingdom)

Author keywords

Barthel index; Rankin scale

Indexed keywords

PROTEIN S 100;

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STROKE;

EID: 0030743845     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329703400405     Document Type: Article

References (20)

1. Moore BW. A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 1965; 19: 739-44
2. Douglas K, Dana CH. The S-100 protein family. TIBS 1988; 13: 437-43
3. Donato R. Perspectives in S-100 protein biology. Cell Calcium 1991; 12: 713-26
4. Isobe T, Ishioka N, Matsuda T, Takahashi Y, Ganno S, Okuyama T. A rapid separation of S-100 subunits, by high performance liquid chromatography: the subunit composition of S-100 proteins. Biochem Int 1983; 6: 419-26
5. Shashoua VE, Hess GW, Moore BW. Proteins of the brain extracellular fluid: evidence of release of S-100 protein. J Neurochem 1984; 42: 1536-41
6. Persson L, Haordemark HG, Gustafsson J, Rundstrom G, Mendel-Hartvig I, Thomas E, et al. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum. Markers of cell damage in human central nervous system. Stroke 1987; 18: 911-8
7. Fagnart OC, Sindic CJM, Laterre C, Particle counting immunoassay of S-100 protein in serum. Possible relevance in tumors and ischemic disorders of the central nervous system. Clin Chem 1988; 34: 1387-91
8. Hardemark HG, Ericsson N, Kotwica Z, Rundstrom G, Mendel-Hartvig I, Oisson Y, et al. S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damage. J Neurosurg 1989; 7: 727-31
9. Mokuno K, Kato K, Kawai K, Matsuoka Y, Yanagi T, Sobue I. Neuro-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases. J Neuro Sci 1983; 63: 443-51
10. Takayasu M, Shibuya M, Kanamori M, Suzuki Y, Ogura K, Kaglyma N, et al. S-100 protein and calmodulin levels in cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg 1985; 63: 417-20
11. Bath PMW, Butterwoth RJ, Soo J, Kerr J. The King's College Hospital Acute Stroke Unit. J R Coll Phys (Lond) 1996; 30: 13-7
12. Mahoney FI, Barthel DW. Functional Evaluation: The Barthel Index. Maryland Med J 1965; 14: 61-5
13. Rankin J. Cerebral vascular accidents in patients over the age of 60: prognosis. Scot Med J 1957; 2: 200-15
14. Lindley RI, Waddell F, Livingstone M, Sandercock P, Dennis MS, Slattery J, et al. Can simple questions assess outcome after stroke? Cerebrovas Dis 1994; 4: 314-24
15. Siegal S, Castellan NJ. Non-parametric Statistics for the Behavioural Sciences, 2nd edn. London: McGraw-Hill, 1988
16. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337: 1521-6
17. Bath PMW. Treating acute ischaemic stroke. BMJ 1995; 311: 139-40
18. Michetti F, Massaro A, Russo G, Rigon G. The S100 antigen in cerebrospinal fluid as a possible index of cell injury in the nervous system. J Neurol Sci 1980; 44: 259-63
19. Sindic CJM, Chalon MP, Cambiaso L, Laterre EC, Masson PL. Assessment of damage of central nervous system by determination of S-100 protein in the cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1982; 45: 1130-5
20. Aurell A, Rosengren LE, Karlsson B, Olsson JE, Zbornikova V, Haglid KG. Determination of S-100 and glial fibrillary acid protein concentration in cerebrospinal fluid after brain infarction. Stroke 1991; 22: 1254-8